SCHEMBL25719261

SCHEMBL25719261

FC(F)(F)Sc1ccc(Cc2nc3c(Cl)c(-c4ccccc4C(F)(F)F)c(Cl)cc3[nH]2)cc1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CACNA1H O95180 2/20 0.41
▸ CACNA1G O43497 1/20 0.41
▸ TRPA1 O75762 1/20 0.38
▸ TRPM8 Q7Z2W7 1/20 0.38
▸ TRPV1 Q8NER1 1/20 0.38
▸ PTGES O14684 11/20 0.34
▸ RHEB Q15382 1/20 0.34
▸ HSD11B1 P28845 1/20 0.33
▸ PRNP P04156 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ PDE10A Q9Y233 1/20 0.32
▸ USP1 O94782 1/20 0.32
▸ WDR48 Q8TAF3 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25719300 0.86 CACNA1H (0.37) CACNA1HCACNA1GTRPA1TRPM8TRPV1
SCHEMBL30116510 0.83 CACNA1H (0.39) CACNA1HCACNA1GTRPA1TRPM8TRPV1
SCHEMBL25716483 0.83 CACNA1H (0.39) CACNA1HCACNA1GTRPA1TRPM8TRPV1
SCHEMBL30116437 0.83 RORC (0.40) CACNA1HCACNA1GTRPA1TRPM8TRPV1
SCHEMBL23000519 0.83 CACNA1H (0.39) CACNA1HCACNA1GTRPA1TRPM8TRPV1
SCHEMBL23000359 0.83 RORC (0.40) CACNA1HCACNA1GTRPA1TRPM8TRPV1
SCHEMBL25716635 0.83 CACNA1H (0.39) CACNA1HCACNA1GTRPA1TRPM8TRPV1
SCHEMBL30116413 0.82 RORC (0.45) CACNA1HCACNA1GPTGESHSD11B1CYP2C9
SCHEMBL23000320 0.82 RORC (0.45) CACNA1HCACNA1GPTGESHSD11B1CYP2C9
SCHEMBL25718660 0.81 CACNA1H (0.38) CACNA1HCACNA1GTRPA1TRPM8TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3781161-B1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA (RORY) AND PHARMACEUTICAL USES THEREOF JIANGSU HENGRUI PHARMACEUTICALS CO LTD (CN) 2023-06-07 — — EP disclosed
Send feedback